Atea Pharmaceuticals

AVIRNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$420.142 M

$5.25 +5.21%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$158.0M

Loss-making

Shares outstanding

79,672,083

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#218Larimar TherapeuticsLRMR$432.2M
#219Assembly BiosciencesASMB$424.0M
#220Atea PharmaceuticalsAVIR$420.1M
#221KamadaKMDA$419.4M
#222Abeona TherapeuticsABEO$412.6M

Where these numbers come from

Share counts and financials for Atea Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.